Home/Filings/4/0001209191-20-024214
4//SEC Filing

Maloberti Renaud Bertrand 4

Accession 0001209191-20-024214

CIK 0001681682other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 4:40 PM ET

Size

5.2 KB

Accession

0001209191-20-024214

Insider Transaction Report

Form 4
Period: 2020-04-09
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2020-04-09+86,58086,580 total
Footnotes (2)
  • [F1]Represents restricted stock units granted in lieu of a portion of the Reporting Person's cash salary. Subject to continued employment, the restricted stock units vest each day, pro rata based on the number of days between the grant date and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Includes unvested restricted stock units.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001744025

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 4:40 PM ET
Size
5.2 KB